SCHEMBL4701201

SCHEMBL4701201

Oc1cccc(COc2ccc(Cl)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.65
MAOB P27338 7/20 0.58
RXRA P19793 1/20 0.56
RXRB P28702 1/20 0.56
RXRG P48443 1/20 0.56
MAOA P21397 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.55
ALOX12 P18054 1/20 0.55
HTT P42858 1/20 0.55
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
PTGS1 P23219 1/20 0.52
SLC6A2 P23975 1/20 0.52
CYP2C19 P33261 1/20 0.52
PTGS2 P35354 1/20 0.52
SLC6A3 Q01959 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3774293 0.89 MRGPRX4 (0.68) MRGPRX4MAOBRXRARXRBRXRG
SCHEMBL21944807 0.86 MRGPRX4 (0.65) MRGPRX4MAOBRXRARXRBRXRG
SCHEMBL21944885 0.84 NR4A2 (0.61) MRGPRX4MAOBRXRARXRBRXRG
SCHEMBL13192629 0.83 LMNA (0.62) MAOBRAB9AALDH1A1LMNACYP1A2
SCHEMBL4697290 0.82 APP (0.70) MAOBRXRARXRBRXRGMAOA
SCHEMBL31533129 0.82 APP (0.70) MAOBRXRARXRBRXRGMAOA
SCHEMBL3624161 0.82 MAOB (0.73) MRGPRX4MAOBRXRARXRBRXRG
SCHEMBL26581162 0.81 MRGPRX4 (0.68) MRGPRX4MAOBRXRARXRBMAOA
SCHEMBL16795800 0.81 MAOB (0.69) MRGPRX4MAOBMAOA
SCHEMBL4698486 0.81 NR4A2 (0.66) MAOBRXRARXRBRXRGMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926737-B1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2017-03-15 EP disclosed
CN-101263145-A 4-amino-thieno [3, 2-C ] pyridine-7-carboxylic acid derivatives HOFFMANN LA ROCHE (CH) 2008-09-10 CN disclosed
EP-1926737-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-06-04 EP disclosed
WO-2007031428-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-03-22 WO disclosed
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BARTKOVITZ DAVID J 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BRAF, RAF1, MAP3K7 MRGPRX4 1794/4885MAOB 1364/4885RXRA 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.